Compound Summary
Neboglamine
Compound Information
Neboglamine
Compound Name: | Neboglamine |
Compound CID: | 3074827 |
Synonyms: | Neboglamine Nebostinel CR 2249 163000-63-3 (S)-4-Amino-5-((4,4-dimethylcyclohexyl)amino)-5-oxopentanoic acid More... |
Iupac Name: | (4S)-4-amino-5-[(4,4-dimethylcyclohexyl)amino]-5-oxopentanoic acid |
InChI: | InChI=1S/C13H24N2O3/c1-13(2)7-5-9(6-8-13)15-12(18)10(14)3-4-11(16)17/h9-10H,3-8,14H2,1-2H3,(H,15,18)(H,16,17)/t10-/m0/s1 |
InChIKey: | VCRGLZYPNNAVRP-JTQLQIEISA-N |
Canonical Smiles: | CC1(CCC(CC1)NC(=O)C(CCC(=O)O)N)C |
Isomeric Smiles: | CC1(CCC(CC1)NC(=O)[C@H](CCC(=O)O)N)C |
Molecular Weight: | 256.34 |
Molecular Formula: | C13H24N2O3 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Neboglamine
Molecular Weight: | 256.34 |
Molecular Formula: | C13H24N2O3 |
Hydrogen Bond Donor Count: | 3 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 5 |
Heavy Atom Count: | 18 |
Complexity: | 305 |
Synonyms
Neboglamine
| Neboglamine | Neboglamine |
|---|---|
Neboglamine |
Nebostinel |
CR 2249 |
163000-63-3 |
(S)-4-Amino-5-((4,4-dimethylcyclohexyl)amino)-5-oxopentanoic acid |
UNII-12EA34U5B8 |
Cr2249 |
12EA34U5B8 |
CR-2249 |
NCGC00094157-01 |
(4S)-4-amino-5-(4,4-dimethylcyclohexyl)amino-5-oxopentanoic acid |
Neboglamine INN |
(S)-4-Amino-5-(4,4-dimethylcyclohexyl)amino-5-oxopentanoic acid |
DSSTox_CID_25787 |
DSSTox_RID_81128 |
DSSTox_GSID_45787 |
Lopac0_000826 |
SCHEMBL1353060 |
ZINC6138 |
(S)-4-Amino-N-(4,4-dimethylcyclohexyl)glutaramic acid |
CHEMBL1255840 |
DTXSID2045787 |
HMS3262F13 |
Tox21_111254 |
Tox21_500826 |
MFCD00932765 |
Pentanoic acid, 4-amino-5-((4,4-dimethylcyclohexyl)amino)-5-oxo-, (S)- |
Pentanoic acid,4-amino-5-(4,4-dimethylcyclohexyl)amino-5-oxo-, (4S)- |
CCG-204910 |
LP00826 |
SDCCGSBI-0050803.P002 |
XY-2401 |
(S)-CR-2249 |
NCGC00094157-02 |
NCGC00094157-03 |
NCGC00094157-04 |
NCGC00261511-01 |
CAS-163000-63-3 |
EU-0100826 |
N 2034 |
A900897 |
SR-01000076022 |
SR-01000076022-1 |
Q20707894 |
4-amino-5-((4,4-dimethylcyclohexyl)amino)-5-oxopentanoic acid |
(s)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoic acid |
Pentanoic acid,4-amino-5-(4,4-dimethylcyclohexyl)amino-5-oxo-,(4S)- |
Experimental Data
Neboglamine
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 1.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
Neboglamine
Statistics Data
Neboglamine
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 1.000000000000000 | 1 | 1 |
Statistics Data Visualization
Neboglamine
